NervGen Pharma Corp. Common stock (NGEN) News

Latest headlines that mention NGEN, newest first · each headline opens the original publisher

NGEN quote

Last price: $1.39
Day change: +4.14%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

NGEN headlines

latest coverage

Not much coverage yet. NGEN has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 28d ago

NervGen doses first patient in phase 3 spinal cord injury trial

General T3NGEN

Seeking Alpha News 1mo ago

NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything

General T2NGEN

Seeking Alpha News 1mo ago

NervGen Pharma Corp. (NGEN) Discusses Challenges and Advances in Drug and Therapy Trials for Spinal Cord Injury Transcript

General T2NGEN

Seeking Alpha 2mo ago

NervGen Pharma GAAP EPS of -C$0.37

Earnings T2NGEN

Investing.com 3mo ago

H.C. Wainwright cuts NervGen stock price target to $15 on dilution

General T3NGEN

Seeking Alpha News 4mo ago

NervGen Pharma: I Think The Biggest Risks Are Now Behind It

General T2NGEN

Seeking Alpha 5mo ago

NervGen rises as TD Cowen issues new Buy on lead asset

General T2NGEN

Seeking Alpha 5mo ago

NervGen Pharma prices 24M share public offering; warrants exercisable at $3.68

General T2NGEN

Investing.com 5mo ago

NervGen prices $60M public offering at $2.50 per share

General T3NGEN

Seeking Alpha 5mo ago

NervGen launches underwritten public offering of shares and warrants

General T2NGEN

Seeking Alpha 5mo ago

NervGen Pharma GAAP EPS of -$0.02

Earnings T2NGEN

Investing.com 5mo ago

Form 6K NervGen Pharma Corp For: 15 May

General T3NGEN

NGEN news alerts

Get an alert by email or push when a new headline mentions NGEN.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.